Legal Representation
Attorney
Jennifer D. Arkowitz,
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 7, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 7, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 12, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 11, 2011 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 6, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 6, 2011 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 19, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 17, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 6, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 6, 2011 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 28, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 26, 2010 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 22, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2010 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 9, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 8, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 5, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 5, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 3, 2009 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Nov 3, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 27, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 7, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 7, 2009 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 7, 2009 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Oct 7, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 7, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 13, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 24, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 9, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 9, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 1, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 1, 2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 1, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 28, 2008 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Nov 21, 2008 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Nov 12, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 7, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 7, 2008 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 7, 2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 7, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 7, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 6, 2008 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Nov 3, 2008 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Oct 20, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 20, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 6, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 2, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 3, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions in the nature of diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulations of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Inhaler devices, sold empty, used to introduce medication into the respiratory system as fine liquid mist for the treatment of respiratory pulmonary conditions; medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of the word "NEKTAR" in the mark is Nectar.
Classification
International Classes
005
010